tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

NRx Pharmaceuticals sees cash runway through 2Q26

The Company believes that its current cash position will support operations at least through the second quarter of 2026, as well as provide sufficient capital to reach expected regulatory inflection points and complete potential additional select acquisition opportunities to expand the growing footprint of HOPE clinics.

TipRanks Black Friday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1